Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.

Home
/
Records
/
Eir
/
Eli Lilly & Company

EIR

•Eli Lilly & Company•January 17, 2020

FDA EIR - Eli Lilly & Company - January 17, 2020

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This EIR record concerns Eli Lilly & Company, with an inspection on January 17, 2020.

Company: Eli Lilly & Company
Inspection Date: January 17, 2020
People: Eva Dokoupilova
Cesar E. Matto (Senior Policy Advisor)
Ashar Parikh Investigator
Jolanna A. (Medical Content Writer)
LaTonya Mitchell-Holmes (Program Division Director)

Open in Dashboard

ID · 00535940-b628-4bcd-aa01-17eb95be770e

Global Key Solutions

Regulatory Data Transformed

Contact

New York Office:

370 Jay Street 7th Floor

Brooklyn, NY 11201

Scranton Office:

Scranton Enterprise Center, Suite 217

201 Lackawanna Avenue

Scranton, PA, 18503

🇺🇸+1 917-789-5099

🇪🇺+48 532-447-507

info@globalkeysolutions.net

Quick Links

KeyPedia™ Lite

Legal & Ethics

©2026, Global Key Solutions All rights reserved.

FDA EIR - Eli Lilly & Company - January 17, 2020 | Global Key Solutions